Jane Street’s Scinai Immunotherapeutics SCNI Stock Holding History

Jane Street’s Portfolio SCNI Stock Details SCNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-124	Closed	-$46K	–	4401
2015 Q3	$46K	Sell	124 -666	-84%	-$272K	﹤0.01%	3443
2015 Q2	$391K	Buy	+790	New	+$372K	﹤0.01%	2534

Other funds holding SCNI

VIA

Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Jane Street's SCNI Position: Q4 2015 in Review

Jane Street sold out of Scinai Immunotherapeutics (SCNI) in Q4 2015, closing a stake of 124 shares — an estimated $46K sold.

Jane Street first reported a position in SCNI in Q2 2015 and held it in 2 quarters. The position peaked at $391K in Q2 2015. 2 funds tracked by Wall St. Rank hold SCNI as of Q4 2015.

Jane Street reported no remaining Scinai Immunotherapeutics position as of Q4 2015 after selling out during the quarter.
Jane Street sold 124 Scinai Immunotherapeutics shares in Q4 2015, an estimated $46K.
Jane Street first reported a position in Scinai Immunotherapeutics in Q2 2015 and held it in 2 quarters.
Jane Street's Scinai Immunotherapeutics position peaked at $391K in Q2 2015.
2 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q4 2015.

Based on Jane Street's 13F filing for Q4 2015, filed 16 Feb 2016.